A MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, MULTI-ARM HISTORICAL CONTROL, COMPARATIVE TRIAL OF THE SAFETY AND EFFICACY OF HYDROXYCHLOROQUINE AND THE COMBINATION OF HYDROXYCHLOROQUINE AND FAMOTIDINE FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 DISEASE
$4,668,079
| Recipient | ALCHEM LABORATORIES CORPORATION UEI LD2KY6H7KMQ5 |
|---|---|
| Award ID | 75A50120C00078 |
| Award amount | $4,668,079 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN13 |
| Start date | Apr 14, 2020 |
| End date | Aug 5, 2024 |
| Place of performance | ALACHUA, FL |
| Record updated | Aug 5, 2024 |
View the official award record
More awards won by ALCHEM LABORATORIES CORPORATION
INTERVENTIONAL AGENTS CHEMISTRY SERVICES
Department of Health and Human Services · $50,000,000 · Sep 15, 2024
NINDS DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP)
Department of Health and Human Services · $49,999,999 · May 4, 2026
IDIQ CHEMISTRY, MANUFACTURING, AND CONTROL (CMC) AND RELATED SERVICES FOR DRUG PRODUCTS
Department of Health and Human Services · $49,885,703 · Aug 1, 2024
EO 14398 IDIQ: CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG SUBSTANCES (TRND 1)
Department of Health and Human Services · $49,713,679 · Aug 1, 2026
ANALYSIS AND SYNTHESIS OF GMP AND NON-GMP BULK DRUGS AND PHARMACEUTICAL FORMULATIONS
Department of Health and Human Services · $12,069,385 · Apr 11, 2023
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids